Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hersey

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 24, 2021
Re: Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancersPeter Hersey
Expert Opinion on Investigational Drugs|January 5, 2002
Advances in the non-surgical treatment of melanomaPeter Hersey
Current Opinion in Oncology|February 8, 2006
Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanomaPeter Hersey
The Lancet. Oncology|March 4, 2014
Community experience of vemurafenib for BRAF(V600) melanomaPeter Hersey
Asia-Pacific Journal of Clinical Oncology|May 21, 2010
Immunotherapy of melanomaPeter Hersey
British Journal of Nursing (Mark Allen Publishing)|February 24, 2017
Developing an e-learning resource for nurse airway assistants in the emergency departmentPeter Hersey, Sean McAleer
Future Oncology (London, England)|January 10, 2015
Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanomaPeter Hersey, Kavitha Gowrishankar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
A focus on PD-L1 in human melanomaPeter Hersey, Stuart Gallagher
Interactive Cardiovascular and Thoracic Surgery|July 26, 2008
Does the administration of mannitol prevent renal failure in open abdominal aortic aneurysm surgery?Peter Hersey, Mike Poullis
Journal of Surgical Oncology|December 5, 2013
Intralesional immunotherapy for melanomaPeter Hersey, Stuart Gallagher
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|December 24, 2021
Re: Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancersPeter Hersey
Expert Opinion on Investigational Drugs|January 5, 2002
Advances in the non-surgical treatment of melanomaPeter Hersey
Current Opinion in Oncology|February 8, 2006
Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanomaPeter Hersey
The Lancet. Oncology|March 4, 2014
Community experience of vemurafenib for BRAF(V600) melanomaPeter Hersey
Asia-Pacific Journal of Clinical Oncology|May 21, 2010
Immunotherapy of melanomaPeter Hersey
British Journal of Nursing (Mark Allen Publishing)|February 24, 2017
Developing an e-learning resource for nurse airway assistants in the emergency departmentPeter Hersey, Sean McAleer
Future Oncology (London, England)|January 10, 2015
Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanomaPeter Hersey, Kavitha Gowrishankar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
A focus on PD-L1 in human melanomaPeter Hersey, Stuart Gallagher
Interactive Cardiovascular and Thoracic Surgery|July 26, 2008
Does the administration of mannitol prevent renal failure in open abdominal aortic aneurysm surgery?Peter Hersey, Mike Poullis
Journal of Surgical Oncology|December 5, 2013
Intralesional immunotherapy for melanomaPeter Hersey, Stuart Gallagher
Pageof 17